Fc receptor inhibitors (Arthron)

N/A

Report date: 2025/03/20 20:00:06

NME

Base Information

Drug NameFc receptor inhibitors (Arthron)

Drug Alias NameSLE therapy (Arthron)TNF release inhibitors (Arthron)rheumatoid arthritis therapy (Arthron)lupus therapy (Arthron)ITP therapy (Arthron) +[6]

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionTNF release inhibitorsImmunomodulators

TargetsUpdating

Therapy Area/IndicationsLupus Erythematosus, SystemicPurpura, ThrombocytopenicArthritis, Rheumatoid

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryAustralia and New Zealand

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesArthron Ltd

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesArthron Ltd

Active IndicationsN/A

Inactive IndicationsLupus Erythematosus, SystemicPurpura, ThrombocytopenicArthritis, Rheumatoid

Other Information

ATC CodeN/A